Featured sources, July 18

  • COVID-19 resources by Evidence Aid: Evidence Aid is a U.K.-based nonprofit that provides evidence-based guidance for disaster response. The organization’s COVID-19 page includes plain-language research summaries about COVID-19 epidemiology, treatments, and more, available in several different languages.
  • Public Health England Technical Briefings on SARS-CoV-2 variants: While the CDC has not done the best job of providing data on variants and breakthrough cases, the U.K.’s public health agency is sequencing more cases than any other country—and providing detailed reports on the results of those efforts. These reports may be useful for anyone seeking to keep a close eye on Delta and other variants’ ability to beat our vaccines. (h/t Your Local Epidemiologist)
  • Excess mortality and COVID-19 deaths in 67 countries: Researchers from the University of Bologna (in Italy) analyzed the gaps between excess deaths and COVID-19 deaths in 67 countries, revealing the capacity of different national health systems to accurately identify COVID-19 cases. Their work was published this week in JAMA Network Open. (For more on excess deaths, see this CDD post about Peru.)
  • Characterizing long COVID in an international cohort: In another new paper, published this week in The Lancet, COVID-19 long-haulers from the Patient-Led Research Collaborative share the results of an international survey on long COVID-19. The findings indicate that the vast majority of long-haulers (over 90% of those surveyed) suffer from symptoms for at least 35 weeks.
  • COVID-19 Vaccine Acceptance and Hesitancy in Low and Middle Income Countries: One more new paper, this one published in Nature: an international group of researchers analyzed vaccine acceptance across several low- and middle-income countries (LMICs), the U.S., and Russia. They found much higher vaccine acceptance in LMICs (80%) compared to the U.S. (65%) and Russian (30%). The study data are available on GitHub.

Leave a Reply